Linkedin X-twitter Youtube
Launch Digital Edition

Webinars and Sponsored Roundtables — Register Now

Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.

Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications. 

Register Now

Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.

Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.

Register Now

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Subspecialties

Interactive Product Guides

Webinars – Register Now

Automated and integrated genomic profiling of hematologic malignancies

Thursday, March 5, 2026
11:00 AM–12:00 PM ET

Learn how EuroClonality-NDC and Myeloid-NDC NGS Workflows are utilized in advancing the future of diagnostics, prognostics, and targeted therapies and how these revolutionary assays provide comprehensive genomic data that reveals mutations, structural variations, and clonal evolution patterns with remarkable resolution, enabling clinical researchers to delve deeper into the genomic landscape of hematological malignancies.

Webinar presenters David Gonzalez, PhD, FRCPath, CEO, Univ8 Genomics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY.

Register Now.

Foundation of HER2 Gastric Cancer ASCO/CAP Guidelines—Overview of the Differences Between ASCO-CAP Breast and Gastric Cancer Scoring

Wednesday, January 28, 2026
12:00 PM–1:30 PM ET

Understand the clinical relevance of HER2 as a biomarker and its importance in cancers beyond breast and gastric. Explore the nuances of HER2 IHC scoring for breast and gastric cancers. Hear expert insights on current gastric ASCO/CAP guidelines for scoring.

Webinar presenters Josef Rüschoff, MD, PhD.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY.

Register Now.

Register for our Upcoming Webinars

Wednesday, September 24, 2025 1:00 PM–2:00 PM ET

Webinar presenters Wendy Vitek, MD, Board-certified Reproductive Endocrinologist, Boston IVF’s Syracuse, NY Fertility Center, and Shirley Li, MD, PhD, Associate Professor-Clinical, Department of Pathology; Director of Clinical Pathology Services and Co-Director of the Clinical Chemistry & Toxicology Laboratory, The Ohio State University, explore Anti-Müllerian Hormone (AMH) from both analytical and clinical perspectives. Gain insights into assay performance, method comparisons, and the practical utility of AMH in reproductive health and infertility treatment.

Tuesday, October 28, 2025 12:00 PM–1:00 PM ET

Webinar presenter Sanam Loghavi, MD, Associate Professor, Dept. of Hematopathology Division of Pathology/Lab Medicine, MD Anderson Cancer Center, presents from a Pathologist’s perspective, this program will allow you to learn and understand the following:

• Prevalence and severity of the FLT3-ITD mutation in AML

• Role of pathology in FLT3 mutation detection

• Patient identification and treatment landscape

A Pathologist’s Perspective: Exploring the Expanded Clinical Utility of HER2 IHC Scoring in Metastatic Breast Cancer

Webinar presenter Pranil K. Chandra, DO, Senior Vice President, Chief Medical Officer, PathGroup, discusses the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer. You will learn about the clinical significance of identifying patients with certain low levels of HER2 in metastatic breast cancer, the evolution of the HER2 spectrum, key considerations that impact HER2 IHC scoring and interpretation, and guidance for pathologists to accurately report HER2 status.

Register for our Upcoming Webinars

Wednesday, May 21, 2025 12:00 PM–1:00 PM ET

Webinar presenter Pranil K. Chandra, DO, Senior Vice President, Chief Medical Officer, PathGroup, discusses the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer.

Tuesday, June 10, 2025 1:00 PM–2:00 PM ET

Webinar presenter Raza Hoda, MD, Staff Pathologist, Cleveland Clinic, Assistant Professor of Pathology, Cleveland Clinic Lerner College of Medicine, discusses the importance of advancements in HER2 testing, including HER2 Ultra Low.

Tuesday, June 17, 2025 1:00 PM–2:00 PM ET

Webinar presenters Emilie Lalonde, PhD, FACMG, Molecular Geneticist and Cytogeneticist, Molecular Diagnostics Division, PaLM, London Health Sciences Centre and St. Joseph’s Health Care, Assistant Professor, Pathology and Laboratory Medicine, Western University, and Cheryl A. Mather, MD Medical Director, Molecular Pathology (North Sector), Alberta Precision Laboratories, Assistant Clinical Professor, Department of Laboratory Medicine & Pathology, University of Alberta, discuss how amplicon-based NGS panels meet biomarker testing guidelines in practice including routine diagnostics, expanded workup, and copy number variation (CNV) detection.

Monday, June 23, 2025 1:00 PM–2:00 PM ET

Webinar presenters Frédérique Penault-Llorca, MD, PhD, General Director, Jean Perrin Center, Professor of Pathology, University of Clermont-Ferrand, France, and Ana Garrido-Castro, MD Breast Oncologist, Dana-Farber Cancer Institute, Assistant Professor, Harvard Medical School, Boston, Massachusetts, discuss strategies for optimizing HER2 IHC testing and reporting, as well as best-practices for overcoming challenges associated with HER2 IHC scoring, especially for lower expression of HER2.

MARKETPLACE

TRENDING